Any feedback?
Literature summary for 3.4.24.68 extracted from
- Production of Recombinant human scFv against tetanus toxin heavy chain by phage display technology (2015), Monoclon. Antib. Immunodiagn. Immunother., 34, 303-309 .
Application
| Application | Comment | Organism |
|---|---|---|
| medicine | HuscFv antibodies specific for heavy chain can protect against tetanus neurotoxin by inhibiting binding of the enzyme to ganglioside GT1b | Clostridium tetani |
Natural Substrates/ Products (Substrates)
| Natural Substrates | Organism | Comment (Nat. Sub.) | Natural Products | Comment (Nat. Pro.) | Rev. | Reac. |
|---|---|---|---|---|---|---|
| vesicle associated membrane protein + H2O | Clostridium tetani | - |
? | - |
? |  |
Organism
| Organism | UniProt | Comment | Textmining |
|---|---|---|---|
| Clostridium tetani | - |
- |
- |
Substrates and Products (Substrate)
| Substrates | Comment Substrates | Organism | Products | Comment (Products) | Rev. | Reac. |
|---|---|---|---|---|---|---|
| vesicle associated membrane protein + H2O | - |
Clostridium tetani | ? | - |
? | |
Synonyms
| Synonyms | Comment | Organism |
|---|---|---|
| TeNT | - |
Clostridium tetani |
| Tetanus neurotoxin | - |
Clostridium tetani |
| tetanus toxin | - |
Clostridium tetani |
Use of this online version of BRENDA is free under the CC BY 4.0 license. See terms of use for full details.
Release 2023.1 (January 2023)
Legal
Curated at
Member of
